Logotype for Avadel Pharmaceuticals plc

Avadel Pharmaceuticals (AVDL) investor relations material

Avadel Pharmaceuticals H.C. Wainwright 27th Annual Global Investment Conference summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Avadel Pharmaceuticals plc
H.C. Wainwright 27th Annual Global Investment Conference summary10 Sep, 2025

Product innovation and adoption

  • LUMRYZ's extended-release, once-at-bedtime dosing aligns with patients' natural sleep cycles and offers robust efficacy, leading to rapid adoption among high-volume prescribers.

  • Persistent expansion in use is observed as physicians transition patients from older therapies and initiate new patients on LUMRYZ, driven by positive real-world outcomes.

  • Growth is supported by both high-volume and lower-volume prescribers, with increasing ease of initiation and strong patient demand.

  • Investments in sales force and fulfillment processes ensure efficient onboarding, compliance, and conversion to reimbursed therapy.

  • Direct-to-patient initiatives are generating increased patient requests for LUMRYZ, further fueling growth.

Market dynamics and growth drivers

  • Both switch patients from older oxybates and treatment-naive patients are driving demand, with LUMRYZ becoming the preferred choice among sleep specialists.

  • Efficacy benefits linked to the once-nightly dosing profile are the primary driver of adoption, with sodium sensitivity considered for a minority of patients.

  • A new licensing agreement will add a no-salt, extended-release oxybate to the portfolio, broadening patient access.

Financial performance and guidance

  • Added 600 patients in the first half of 2025, achieving profitability across cash flow, operating income, and net income.

  • Despite a $20 million upfront payment for a recent deal, expectations remain for net cash flow positivity for the year.

  • Revenue guidance updated twice in 2024, now set at $265–$275 million, with confidence in achieving targets.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Avadel Pharmaceuticals earnings date

Logotype for Avadel Pharmaceuticals plc
Q3 202511 Nov, 2025
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Avadel Pharmaceuticals earnings date

Logotype for Avadel Pharmaceuticals plc
Q3 202511 Nov, 2025

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Avadel Pharmaceuticals plc is a biopharmaceutical company focused on developing and commercializing innovative treatments for chronic conditions, particularly in the central nervous system (CNS) field. The company's flagship product, LUMRYZ™, is an extended-release formulation of sodium oxybate used to treat cataplexy and excessive daytime sleepiness in adults with narcolepsy. The company is headquartered in Dublin, Ireland, and its shares are listed on the NASDAQ.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage